ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Bears Pile In: Hertz, Wolfspeed, and Biotech in Focus

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Short sellers tightened their grip on several names this week. Hertz Global Holdings stands out as one of the most extreme cases in US markets. Short interest sits at 73.4% of free float. The cost to borrow has rocketed to 470%, and available shares to borrow have hit zero.

Wolfspeed is in similarly dire shape. The semiconductor maker carries 88.9% of its free float sold short. No shares remain available to borrow. The stock has fallen 27.6% over three months.

The week's biggest mover on fresh short pressure was Braveheart Bio. Its SI jumped 6.7 percentage points in seven days to reach 43.5% of free float. The biotech has a market cap of $1.5 billion, making the move harder to dismiss as a small-cap quirk.

MGM Resorts also drew fresh shorts. Its SI climbed 2.3 points to 14.3% of free float. Casino and leisure stocks face pressure as the US job market runs hot. October nonfarm payrolls hit their highest October reading since 1997 at 159.3 million, pushing wage expectations higher and squeezing consumer-facing margins.

On the other side, shorts covered hard in Sprouts Farmers Market. Its SI fell 3.2 points to 11.2%. Kimberly-Clark saw a 2.8-point drop in SI to 5.8%. Both suggest short sellers are stepping back from consumer staples.

Polestar reports earnings on 12 November. ORTEX Alt Data tracking Dutch and German car registrations shows Dutch sales running 68% below last year's quarter, a dataset with a strong 60-day lead on revenue.

Stocks in this article

How this article was generated

Generated
7 Nov 2026, 20:03
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationAlt DataIndex Rebalance

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.